Evidence map›Paper›PMID 39253813›Full record

ArticleCirculation2024

Glucosamine-Mediated Hexosamine Biosynthesis Pathway Activation Uses ATF4 to Promote "Exercise-Like" Angiogenesis and Perfusion Recovery in PAD.

Suhib Alhusban, Mohamed Nofal, Anita Kovacs-Kasa, Taylor C Kress, M Murat Koseoglu, Abdelrahman A Zaied, Eric J Belin de Chantemele, Brian H Annex

Abstract read
In one paragraph

Article in Circulation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Glucose metabolism in osteoporosis: A potential therapeutic target (Review).International journal of molecular medicine · 2026
    Review
  2. Experimental physiology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. [Application study of platelet-rich plasma combined with arterial supercharging technique to enhance survival of ischemic cross-body region skin flaps in rabbits].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2025
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Suhib AlhusbanVascular Biology Center (S.A., M.N., A.K.-K., T.C.K., M.M.K., A.A.Z., E.J.B.d.C., B.H.A.), Medical College of Georgia at Augusta University.ORCID 0000-0002-4306-4632
Mohamed NofalVascular Biology Center (S.A., M.N., A.K.-K., T.C.K., M.M.K., A.A.Z., E.J.B.d.C., B.H.A.), Medical College of Georgia at Augusta University.
Anita Kovacs-KasaVascular Biology Center (S.A., M.N., A.K.-K., T.C.K., M.M.K., A.A.Z., E.J.B.d.C., B.H.A.), Medical College of Georgia at Augusta University.ORCID 0000-0001-7244-5517
Taylor C KressVascular Biology Center (S.A., M.N., A.K.-K., T.C.K., M.M.K., A.A.Z., E.J.B.d.C., B.H.A.), Medical College of Georgia at Augusta University.ORCID 0000-0003-2615-3788
M Murat KoseogluVascular Biology Center (S.A., M.N., A.K.-K., T.C.K., M.M.K., A.A.Z., E.J.B.d.C., B.H.A.), Medical College of Georgia at Augusta University.
Abdelrahman A ZaiedVascular Biology Center (S.A., M.N., A.K.-K., T.C.K., M.M.K., A.A.Z., E.J.B.d.C., B.H.A.), Medical College of Georgia at Augusta University.ORCID 0000-0002-2919-5329
Eric J Belin de ChantemeleVascular Biology Center (S.A., M.N., A.K.-K., T.C.K., M.M.K., A.A.Z., E.J.B.d.C., B.H.A.), Medical College of Georgia at Augusta University.ORCID 0000-0002-0184-3830
Brian H AnnexVascular Biology Center (S.A., M.N., A.K.-K., T.C.K., M.M.K., A.A.Z., E.J.B.d.C., B.H.A.), Medical College of Georgia at Augusta University.ORCID 0000-0001-6538-8243

Funding

Clinical Phenotyping and Disease Specific Sampling to Identify Non-coding RNAs for Human Therapeutics in PADR01HL150003 · NHLBI · AUGUSTA UNIVERSITY · PI ANNEX, BRIAN H, MCCLUNG, JOSEPH MATTHEW · 2020 to 2023
$3.0M
Precision Medicine for Therapeutic Angiogenesis in Peripheral Arterial Disease: Targeting of the IL21R PathwayR01HL148590 · NHLBI · AUGUSTA UNIVERSITY · PI ANNEX, BRIAN H · 2019 to 2022
$2.9M
The Anti-angiogenic VEGF165b and VEGFR1 Signaling in Peripheral Artery DiseaseR01HL141325 · NHLBI · UNIVERSITY OF VIRGINIA · PI ANNEX, BRIAN H · 2019 to 2022
$2.7M
Novel mechanisms of HIV-associated pulmonary vascular diseaseR01HL176323 · NHLBI · AUGUSTA UNIVERSITY · PI Eric J Belin de Chantemele, Laszlo Kovacs · 2024 to 2026
$2.3M
Mechanism of cardiovascular disease in premenopausal womenR01HL155265 · NHLBI · AUGUSTA UNIVERSITY · PI BELIN DE CHANTEMELE, ERIC J · 2021 to 2024
$2.1M
Leptin in HIV associated vascular diseasesR01HL147639 · NHLBI · AUGUSTA UNIVERSITY · PI BELIN DE CHANTEMELE, ERIC J · 2020 to 2023
$2.0M
Mechanisms of HIV-associated HypertensionR01HL175471 · NHLBI · AUGUSTA UNIVERSITY · PI Eric J Belin de Chantemele · 2024 to 2026
$2.0M
NHLBI NIH HHS R01 HL141325NHLBI NIH HHS R01 HL147639NHLBI NIH HHS R01 HL148590NHLBI NIH HHS R01 HL150003NHLBI NIH HHS R01 HL155265NHLBI NIH HHS R01 HL175471NHLBI NIH HHS R01 HL176323
6 · The paper itself

Abstract

backgroundEndothelial cells (ECs) use glycolysis to produce energy. In preclinical models of peripheral arterial disease, further activation of EC glycolysis was ineffective or deleterious in promoting hypoxia-dependent angiogenesis, whereas pentose phosphate pathway activation was effective. Hexosamine biosynthesis pathway, pentose phosphate pathway, and glycolysis are closely linked. Glucosamine directly activates hexosamine biosynthesis pathway.

methodsHind-limb ischemia in endothelial nitric oxide synthase knockout (eNOS

resultsOn day 3 after hind-limb ischemia, glucosamine-treated versus control eNOS

conclusionsIn cells, mice, and humans, activation of hexosamine biosynthesis pathway by glucosamine in peripheral arterial disease induces an "exercise-like" angiogenesis and offers a promising novel therapeutic pathway to treat this challenging disorder.

Indexed as

GlucosamineHexosaminesMice, Inbred BALB CNeovascularization, PhysiologicAngiogenesisAnimalsDisease Models, AnimalFemaleGlycolysisHindlimbHumansHuman Umbilical Vein Endothelial CellsIschemiaMaleMiceMice, KnockoutGlucosamineHexosaminesNitric Oxide Synthase Type IIIangiogenesisendothelial cellsglucosamineoxidative phosphorylationperipheral arterial diseasereactive oxygen species

Identifiers

PMID39253813
PMCPMC11955094

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.